2nd Annual RNA Therapeutics Summit

Vonlanthen Group of Companies is pleased to invite you to the 2nd Annual RNA Therapeutics Summit on October 19th – 20th, 2017 in Barcelona, Spain. At this Summit, we will highlight the latest innovations, clinical developments, and key lessons for the future development of RNA Therapeutics.

This Summit brings together professionals from across the industry and academia to expand the scientific horizons in RNA-based Therapeutics. Experts will discuss collective experiences, current progress, and identify future prospects and possibilities.

We are looking forward to your participation in this engaging Summit in Barcelona, this coming October!

Key Practical Learning Points of the Summit:

  • Challenges effecting targeted delivery and overcoming biological barriers
  • New directions in therapies, regulatory overview
  • Antisense oligonucleotide drugs
  • Immunology oligonucleotides
  • Gene-based therapies
  • Results of clinical trials
  • How to commercialise novel RNA Therapeutics
  • Key developments currently shaping the industry

Who Should Attend:

Chief Executives, Directors, Vice Presidents, Department Heads, Leaders, Scientists, Laboratory Heads, Investigators and Managers specialising in:

  • Biotechnology
  • Gene/antisense/ RNA therapy
  • Nanomedicine
  • Research and Development
  • Formulation
  • RNA Biochemistry
  • Cancer Immunotherapy
  • Cancer Genomics
  • Clinical Trials
  • Infection and Immunity
  • Cell Therapy
  • Molecular Biology
  • Pharmaceutical Development
  • Vaccines Development
  • Drug delivery
  • Drug Safety
  • Regulatory